76 related articles for article (PubMed ID: 8557140)
21. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
22. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study.
Potashnik G; Lerner-Geva L; Genkin L; Chetrit A; Lunenfeld E; Porath A
Fertil Steril; 1999 May; 71(5):853-9. PubMed ID: 10231045
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome.
Nahid L; Sirous K
Minerva Ginecol; 2012 Jun; 64(3):253-8. PubMed ID: 22635021
[TBL] [Abstract][Full Text] [Related]
24. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
Casper RF; Mitwally MF
Clin Obstet Gynecol; 2011 Dec; 54(4):685-95. PubMed ID: 22031258
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
Rouzi AA; Ardawi MS
Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
[TBL] [Abstract][Full Text] [Related]
26. Comparison of treatment outcomes of infertile women by clomiphene citrate and letrozole with gonadotropins underwent intrauterine insemination.
Zadehmodares S; Niyakan M; Sharafy SA; Yazdi MH; Jahed F
Acta Med Iran; 2012; 50(1):18-20. PubMed ID: 22267373
[TBL] [Abstract][Full Text] [Related]
27. Ovarian cancer after successful ovulation induction: a case report.
Hull ME; Kriner M; Schneider E; Maiman M
J Reprod Med; 1996 Jan; 41(1):52-4. PubMed ID: 8855076
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of baseline ovarian cysts in clomiphene citrate ovulation cycles.
Frattarelli JL; Dempsey MS
Fertil Steril; 2004 Oct; 82(4):979-81. PubMed ID: 15482788
[TBL] [Abstract][Full Text] [Related]
29. Transaminitis after treatment with clomiphene citrate: a case report.
Mitchell C; Gottlieb L
J Reprod Med; 2007 May; 52(5):437-8. PubMed ID: 17583249
[TBL] [Abstract][Full Text] [Related]
30. The effects of ovulation induction during infertility treatment on gingival inflammation.
Haytaç MC; Cetin T; Seydaoglu G
J Periodontol; 2004 Jun; 75(6):805-10. PubMed ID: 15295945
[TBL] [Abstract][Full Text] [Related]
31. Heterotopic pregnancy following ovulation induction by clomiphene citrate and timed intercourse: a case report.
Naki MM; Tekcan C; Uysal A; Güzin K; Yücel N
Arch Gynecol Obstet; 2006 Jun; 274(3):181-3. PubMed ID: 16463167
[TBL] [Abstract][Full Text] [Related]
32. Treatment of clomiphene citrate-related ovarian cysts in a prospective randomized study. A single center experience.
Altinkaya SO; Talas BB; Gungor T; Gulerman C
J Obstet Gynaecol Res; 2009 Oct; 35(5):940-5. PubMed ID: 20149045
[TBL] [Abstract][Full Text] [Related]
33. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
[TBL] [Abstract][Full Text] [Related]
34. Ovulation induction treatment and risk of borderline ovarian tumors.
Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
[TBL] [Abstract][Full Text] [Related]
35. Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study.
Tredway D; Schertz JC; Bock D; Hemsey G; Diamond MP
Fertil Steril; 2011 Apr; 95(5):1720-4.e1-8. PubMed ID: 21300344
[TBL] [Abstract][Full Text] [Related]
36. Infertility, fertility treatment, and risk of hypertension.
Farland LV; Grodstein F; Srouji SS; Forman JP; Rich-Edwards J; Chavarro JE; Missmer SA
Fertil Steril; 2015 Aug; 104(2):391-7. PubMed ID: 26049054
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
[TBL] [Abstract][Full Text] [Related]
38. Childhood tumor risk after treatment with ovulation-stimulating drugs.
Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
[TBL] [Abstract][Full Text] [Related]
39. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
[TBL] [Abstract][Full Text] [Related]
40. Infertility evaluation and management. Strategies for family physicians.
Case AM
Can Fam Physician; 2003 Nov; 49():1465-72. PubMed ID: 14649985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
